ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ESLA Estrella Immunopharma Inc

1.16
0.00 (0.00%)
Pre Market
Last Updated: 09:10:00
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Mar 2024Jun 2024Sep 2024
USD (US$)USD (US$)USD (US$)
Total Revenue 00000000
Operating Income -549k-1.5M-150k-169k0-470k-3.95M-3.38M
Pre Tax Income -345k-69k-44k-55k99k-470k-3.95M-3.38M
Net Income -345k-150k-63k-76k139k-470k-3.95M-3.38M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -549k-1.5M-150k-169k0-470k-3.95M-3.38M
EBITDA -549k-1.5M-150k-169k0-470k-3.95M-3.38M
Year End 30 June 2024 202120222024
USD (US$)USD (US$)USD (US$)
Total Revenue 000
Operating Income -249k-1.57M-7.31M
Pre Tax Income -248k-915k-7.31M
Net Income -248k-996k-7.31M
Preferred Dividends 000
Basic Earnings Per Share (EPS) -0.042-0.427-0.196
EBIT -249k-1.57M-7.31M
EBITDA -249k-1.57M-7.31M

Your Recent History

Delayed Upgrade Clock